Purchases and Sales Made in Q4 2023 in Haemonetics Corp (HAE)
This table provides information about the institutional ownership of Haemonetics Corp (HAE) during Q4 2023. The information is specifically focused on institutions that hold shares of HAEMONETICS CORP.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-114K- 21.98% |
$9.21M - $10.6M
|
406K
$25.6M
|
|
|
Feb 13, 2024
Q4 2023
|
Schroder Investment Management Group
London, X0 |
SELL
|
- |
-115K- 14.91% |
$9.28M - $10.7M
|
657K
$41.4M
|
|
|
Feb 05, 2024
Q4 2023
|
Victory Capital Management Inc
|
SELL
|
- |
-150K- 41.97% |
$12.1M - $13.9M
|
207K
$13.1M
|
|
|
Feb 06, 2024
Q4 2023
|
Ken Fisher
Fisher Asset Management, LLC | Camas, Wa
|
SELL
|
- |
-151K- 17.53% |
$12.2M - $14M
|
711K
$44.8M
|
|
|
Nov 14, 2024
Q4 2023
|
Neuberger Berman Group LLC
New York, NY |
SELL
|
- |
-303K- 7.9% |
$24.4M - $28M
|
3.53M
$223M
|